Completed NA INTERVENTIONAL 2-arm NCT02110238

Non-Inferiority Study Comparing 3 Weekly Injections of SUPARTZ® vs 3 Weekly Injections of Euflexxa® for Knee OA

Multicenter, Randomized, Double-Blind, Parallel Controlled Non-Inferiority Clinical Trial Comparing 3 Weekly Intra-articular Injections of SUPARTZ® vs 3 Weekly Intra-articular Injections of Euflexxa® for Treatment of Knee OA

Sponsor: Bioventus LLC

Conditions Osteoarthritis

Interventions Euflexxa Supartz

Updated 7 times since 2017 Last updated: Feb 12, 2021 Started: Mar 31, 2014 Primary completion: Nov 30, 2014 Completion: Feb 28, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02110238, this NA trial focuses on Osteoarthritis and remains completed. Sponsored by Bioventus LLC, it has been updated 7 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Apr 2021 — Jul 2024 [monthly]

Completed NA

Phase: PHASE3 → NA
Jan 2021 — Apr 2021 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bioventus LLC
Seikagaku Corporation

Data source: Bioventus LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Durham, United States